Let me get this Promisneurosciences into Phase 1 correct?Let me see if i understand this correctly?
They recieve the IND filing in May after many delays which i assume points out a plan on how they can proceed into the clinic?
Then psoted on July 27th, after recieving the IND ,Promis Corporate overview states:
"PMN310 First-in-Human Single Ascending Dose PK Study 22 • Inpatient single dose escalation study of PMN310 and placebo, N=8 per cohort (6:2), in healthy volunteers • Planned fixed IV doses of PMN310 equivalent to approximately 2.5 - 60 mg/kg; high dose will be informed by results of early cohorts • Data expected to be available mid-2023"
Then on 2023-10-07 heading into the 7th month after recieving IND approval they begin to post on the Gov Clinical trial site, not yet recruiting.
So i'll post this question again Elliot? After recieving the IND why were they not in the Clinic in May?
Not enought time to prepare for 8 volunteers, someone earlier said it was the cost they had to do another PP back in August, MPT and BOD's participating. Really?
"Participants seeking only new healthy volunteer trials tended to screen for three studies per year, participate in one or two studies, and earn roughly US$4000 annually."
Mike Gordon and Jeremy Sclar of the Boston Group must be laughing and laughing as they continue to add shares through PP's at company all time low prices. For the Boston group and MPT it's all about delay, delay, delay, and now another year with no meaningful news but in the mean time they will probably continue to acquire cheap, cheap stock!
On the bright side the estimated completion date of July next year coincides perfectly with another Alzheimers conference, in which they might be able to present some information on PMN 310 an antibody developed for Alzheimers disease. When asked by Analysts how it worked in Alzheimers they will have to respond with we don't actually know we didn't test it in Alzheimers patients but we also we didn't test it in Cancer or Covid pateints just healthy volunteers. The Boston group executing another stock sleeper!!